Today: 5 June 2026
Browse Category

Artificial Intelligence 8 February 2026 - 9 February 2026

Amazon stock (AMZN) flat before the bell as $200B AI spending plan stays in focus

Amazon stock (AMZN) flat before the bell as $200B AI spending plan stays in focus

Amazon shares were flat in premarket trading Monday at $210.31 after falling 5.6% Friday, as investors reacted to the company’s plan to boost 2026 capital spending to $200 billion. The increased spending, mainly for AI infrastructure, has raised concerns over cash flow and margins. AWS revenue grew 24% last quarter, trailing Google Cloud and Microsoft Azure. Markets await U.S. jobs and inflation data this week for further direction.
9 February 2026
··
Corning stock (GLW) edges up in premarket after record close as Meta AI data-center deal stays in focus

Corning stock (GLW) edges up in premarket after record close as Meta AI data-center deal stays in focus

Corning shares climbed 1.8% to $124.40 in premarket trading Monday after closing at a record $122.16 Friday. The rally follows a supply deal with Meta Platforms worth up to $6 billion for optical fiber and cable. Corning reported Q4 2025 core sales of $4.41 billion and forecast Q1 core sales of $4.2–$4.3 billion. Investors are watching whether demand from big tech customers holds as regular trading opens.
9 February 2026
···
IBM and Meta bring AI Alliance to Indonesia as IBM shares rise; Australia reviews Confluent deal

IBM and Meta bring AI Alliance to Indonesia as IBM shares rise; Australia reviews Confluent deal

IBM and Meta have expanded their AI Alliance to Indonesia, aiming to boost open-source AI adoption and training. The alliance now includes 195 members in 29 countries. IBM’s $11 billion acquisition of Confluent remains under review by Australia’s competition regulator, with public submissions due by Feb. 12. Many Indonesian firms report unclear returns from new AI systems despite rising adoption.
9 February 2026
·····
AI stocks brace for a big week: Micron slips on Samsung HBM4 talk as Nvidia looms

AI stocks brace for a big week: Micron slips on Samsung HBM4 talk as Nvidia looms

Micron shares fell 3% premarket after reports that Samsung will begin mass production of HBM4 memory for Nvidia AI chips this month. Nvidia dropped 1%, Super Micro Computer slipped 1.5%, while Microsoft and Amazon edged higher. Traders focused on upcoming U.S. jobs and inflation data for rate signals. Nvidia reports earnings Feb. 25.
9 February 2026
···········
Nvidia’s Jensen Huang calls Meta AI’s profit pioneer as spending fears swirl

Nvidia’s Jensen Huang calls Meta AI’s profit pioneer as spending fears swirl

Meta forecast 2026 capital expenditures of $115 billion to $135 billion as fourth-quarter revenue rose 24% to $59.9 billion and earnings per share hit $8.88. CEO Mark Zuckerberg cited strong 2025 performance, while Nvidia’s Jensen Huang told CNBC that Meta leads in AI profitability. Meta’s ad upgrades lifted Facebook clicks 3.5% and Instagram conversions over 1% in Q4.
9 February 2026
··
Datavault AI (DVLT) stock rises in premarket after Friday’s 33% spike — what investors watch next

Datavault AI (DVLT) stock rises in premarket after Friday’s 33% spike — what investors watch next

Datavault AI Inc shares climbed about 4% to $0.884 in premarket trading Monday after a 32.9% jump Friday. The company last week reported preliminary 2025 revenue of at least $30 million, up from $2.7 million in 2024, and announced $49 million in new agreements. No new press releases have been issued since Feb. 5. Token distribution is set to begin Feb. 21.
9 February 2026
··
Billionaires Buy These AI Stocks Up 2,000% — and It’s Not Nvidia or Broadcom

Billionaires Buy These AI Stocks Up 2,000% — and It’s Not Nvidia or Broadcom

Ken Griffin, Cliff Asness, Israel Englander, and Steven Cohen bought shares of Palantir Technologies and Comfort Systems USA in the third quarter, according to a new report. Palantir shares have surged about 2,000% since January 2023, while Comfort Systems is up 970%. Palantir rose 4.5% and Comfort Systems 7% in premarket trading Monday. Robinhood Markets gained 14%, and Nvidia and Broadcom each rose 7%.
9 February 2026
····
Goldman Sachs stock jumps after Anthropic AI “agents” plan as traders size up a big week

Goldman Sachs stock jumps after Anthropic AI “agents” plan as traders size up a big week

Goldman Sachs shares rose 4.3% to $928.75 Friday as U.S. stocks rallied, with the Dow closing above 50,000 for the first time. Goldman confirmed it is working with AI startup Anthropic on internal automation tools, aiming to launch them soon. The bank also helped lead Once Upon a Farm’s $198 million IPO and issued $25.75 million in structured notes. Treasury Secretary Scott Bessent said the Fed may wait up to a year before shrinking its balance sheet.
8 February 2026
···
Amazon’s $200 billion AI spending plan rattles tech stocks — what traders watch next week

Amazon’s $200 billion AI spending plan rattles tech stocks — what traders watch next week

Amazon projected about $200 billion in capex for 2026, far above analyst expectations, sending its shares down 5.6% Friday. The Nasdaq rose 2.18% as chipmakers surged, with Nvidia up 7.8%. About $1 trillion in market value has been wiped from the S&P 500 software and services index since Jan. 28. Wall Street’s tech sector is down roughly 9% from its late-October peak.
8 February 2026
······
Cloud computing stocks bounce back — SKYY jumps, but Amazon’s AI spending plan keeps nerves high

Cloud computing stocks bounce back — SKYY jumps, but Amazon’s AI spending plan keeps nerves high

Cloud-focused ETFs rose 2%–4% Friday as tech stocks rebounded, with the First Trust Cloud Computing ETF up 4.4%. Amazon dropped 5.6% on concerns over $200 billion in planned AI infrastructure spending. Snowflake jumped 7.5% and Microsoft gained 1.8%. U.S. jobs and inflation data due later this week could shift rate expectations and impact high-growth cloud shares.
8 February 2026
·······
Big Tech stocks brace for AI spending scrutiny after Nvidia’s jump and Amazon’s drop

Big Tech stocks brace for AI spending scrutiny after Nvidia’s jump and Amazon’s drop

The Dow closed above 50,000 for the first time Friday as Nvidia surged 7.9% and Amazon dropped 5.6% on news of a $200 billion capex plan for 2026. Tech stocks remain volatile, with chipmakers rallying and software names under pressure as investors react to soaring AI infrastructure costs. The S&P 500 rose 2%, while the Russell 2000 jumped 3.5%. Alphabet, Meta, and Microsoft are also expected to boost spending sharply this year.
8 February 2026
·········
Amazon stock slides on $200 billion AI spending plan as Wall Street braces for jobs, CPI

Amazon stock slides on $200 billion AI spending plan as Wall Street braces for jobs, CPI

Amazon shares fell 5.6% to $210.32 Friday after the company projected over 50% higher capital spending this year, unsettling investors. The company reported Q4 net sales up 14% to $213.4 billion and AWS revenue up 24%. Analysts flagged concerns over the scale of Amazon’s AI infrastructure investment. U.S. retail sales, jobs, and inflation data are due next week.
8 February 2026
···
Dow hits 50,000 — jobs and inflation data loom after Wall Street’s AI-fueled rebound

Dow hits 50,000 — jobs and inflation data loom after Wall Street’s AI-fueled rebound

The Dow Jones Industrial Average closed above 50,000 for the first time Friday, ending at 50,115.67 after a 2.47% jump. Caterpillar and Nvidia led gains as chip stocks rebounded, while Amazon fell 5.6% on plans for higher AI spending. Key U.S. jobs and inflation data releases were postponed to next week after a government funding lapse. Coca-Cola and Cisco are set to report earnings on Feb. 10 and Feb. 11, respectively.
8 February 2026
······
Microsoft stock hovers near $400 as AI spending nerves meet a big data week

Microsoft stock hovers near $400 as AI spending nerves meet a big data week

Microsoft closed Friday up 1.9% at $401.14, near the $400 mark after a turbulent week for tech stocks. Investors are weighing the impact of a $600 billion AI spending push on profits, while upcoming U.S. jobs and inflation data may affect rate expectations and tech valuations. Analyst Brad Reback downgraded Microsoft to “hold,” citing competition and margin concerns.
8 February 2026
··
Big Tech’s $630B AI data-center spending surge is squeezing chips, electricians — and investor patience

Big Tech’s $630B AI data-center spending surge is squeezing chips, electricians — and investor patience

Amazon shares fell 9% Friday after announcing a $200 billion capital spending plan for 2026. Alphabet and Meta also outlined record capex, raising concerns about free cash flow and forcing potential cuts to buybacks or increased borrowing. Investors punished several tech stocks, including Amazon, Alphabet, Meta, ServiceNow, and Salesforce, while Nvidia rose. The surge in AI infrastructure spending is straining supply chains and power capacity.
8 February 2026
·····
Alphabet stock sinks on AI spending fears — what to watch for Google shares next week

Alphabet stock sinks on AI spending fears — what to watch for Google shares next week

Alphabet shares fell 2.5% to $322.86 Friday, lagging a broader tech rally as investors reacted to reports the company may double AI infrastructure spending this year. The Dow closed above 50,000 for the first time. Wall Street is shifting focus from AI demos to cash flow, putting pressure on Big Tech. Key U.S. jobs and inflation data are expected this week.
8 February 2026
···
1 … 55 56 57 58 59 … 203

Stock Market Today

  • MoonLake Immunotherapeutics CFO Sells Small Stake Under Prearranged Plan, No Investor Alarm
    June 4, 2026, 10:41 PM EDT. MoonLake Immunotherapeutics (MLTX) CFO Matthias Bodenstedt sold 13,653 shares, about 1.1% of his holdings, in a Rule 10b5-1 trading plan on May 11, 2026. This plan allows insiders to sell shares on a preset schedule to avoid allegations of insider trading. Bodenstedt retains over 1.17 million shares, valued at $22 million post-transaction. The sale is smaller than his April 2026 disposition and involves no derivative holdings. MoonLake, a clinical-stage biotech developing sonelokimab for inflammatory diseases, faces a 63% share price drop over the past year but remains a high-risk, potentially high-reward stock with positive drug trial results. Analysts largely rate it a Buy despite the firm's pre-revenue status and significant net losses.

Latest articles

Dow Hits Record, But Wall Street Watches After-Hours Session

Dow Hits Record, But Wall Street Watches After-Hours Session

5 June 2026
Dow soared to a record close, but after-hours jitters hit as Broadcom missed revenue expectations and cut its AI-chip forecast, dragging chip stocks and exposing markets to Friday’s key jobs report, which could sway rates, yields, and tech valuations. Lululemon shares plunged 11% after slashing its profit outlook.
AT&T Stock Drops, Investors Eye SpaceX’s Move

AT&T Stock Drops, Investors Eye SpaceX’s Move

5 June 2026
AT&T shares plunged 3.3% to $22.77 after a Supreme Court loss and an Oppenheimer downgrade citing rising satellite broadband competition, as SpaceX’s $75 billion IPO nears; investors fear AT&T’s fiber-heavy strategy faces new risks, with Oppenheimer warning broadband and mobile growth could be at risk from low Earth orbit rivals.
Marvell rises as chip peers drop, Wall Street eyes index move

Marvell rises as chip peers drop, Wall Street eyes index move

5 June 2026
Marvell jumped 4.9% to $316.43, defying a chip selloff, as traders bet on S&P 500 inclusion and Nvidia-linked AI demand; the stock later slipped to $305.18 after hours, with volume more than double average, as investors await Friday’s S&P announcement and weigh risks of high expectations and index flows.
Guidewire Beats Earnings but Shares Drop on Revenue Number

Guidewire Beats Earnings but Shares Drop on Revenue Number

5 June 2026
Guidewire Software plunged 13.77% after hours to $130.36 as investors fixated on annual recurring revenue guidance that missed Wall Street’s target by a narrow margin, overshadowing strong earnings and revenue beats; the stock’s sharp drop highlights concerns over contract growth pacing despite raised full-year outlooks and robust financials.
Go toTop